Molecular Partners
MOLN
8 hedge funds and large institutions have $6.17M invested in Molecular Partners in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
4% more capital invested
Capital invested by funds: $5.93M → $6.17M (+$237K)
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.14% less ownership
Funds ownership: 2.7% → 2.56% (-0.14%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$100K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$21.2K |
| 2 |
HNWAG
High Net Worth Advisory Group
Naples,
Florida
|
-$7K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$6K |
MOLN Hedge Fund Activity: Q3 2022 in Review
8 of the 5,827 institutional investors tracked by Wall St. Rank reported a position in Molecular Partners (MOLN) for Q3 2022, worth a combined $6.17M — up 4% from $5.93M a quarter earlier.
Fund positioning in MOLN was balanced in Q3 2022: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Tang Capital Management, opening a new position worth an estimated $100K. The largest seller was Jane Street, cutting an estimated $21.2K.
- 8 institutional investors held Molecular Partners (MOLN) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $6.17M of Molecular Partners stock for Q3 2022, up 4% quarter-over-quarter.
- 2 funds opened new Molecular Partners positions in Q3 2022 and 2 closed out, a net change of 0 holders.
- The largest Molecular Partners buyer in Q3 2022 was Tang Capital Management, an estimated $100K added.
- The largest Molecular Partners seller in Q3 2022 was Jane Street, an estimated $21.2K sold.
Based on aggregated 13F filings for Q3 2022.